Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers April 22, 2018
Pharmacy Choice - News - Drug Delivery Systems - April 22, 2018

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 105     Next >>     Go To Page:

4/22/18 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 11759) - Meeting
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting of the Arthritis Advisory Committee to discuss new drug application 207924, for baricitinib tablets, submitted by Eli Lilly and Company, for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate resp
4/21/18 - Bluebird Bio One Step Closer to First Approved Drug [Arab News (Saudi Arabia)]
Bluebird bio, headquartered in Cambridge, Massachusetts, announced interim data from two different two-year clinical trials of LentiGlobin gene therapy for transfusion-dependent beta-thalassemia. The two studies are Northstar, which was recently completed, and HGB-205, which is still proceeding. These interim data demonstrate the potential of...
4/21/18 - FDA Takes New Steps to Advance the Development of Innovative Products for Treating Opioid Use Disorder
The first guidance, released today, explains the FDA's current thinking about drug development and clinical trial design issues relevant to the study of sustained-release "depot" buprenorphine products. "Today's action by FDA reflects the Trump Administration's commitment to bringing the best science we have to bear in the fight against opioid add
4/21/18 - Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO (fosnetupitant/ palonosetron) in the United States
-Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO in the United States. Lugano, Switzerland April 20, 2018- Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that the U.S. Food and Drug Administration has approved the intravenous formulation of AKYNZEO as an alternative
4/21/18 - Novel Drug Delivery Systems in Cancer Therapy Market Set to Record Exponential Growth by 2020
Albany, NY 04/21/2018 The persistent rise in the incidence of different types of cancer is the primary factor driving the global Novel Drug Delivery System In Cancer Therapy Market, says Transparency Market Research in its latest report. On the basis of geography, the global NDDS in cancer therapy market is segmented into North America, Asia
4/21/18 - Sen. Baldwin Joins Colleagues to Call on Administration to Take Immediate Action to Reduce Price of Life-Saving Opioid Overdose Reversal Drug
Tammy Baldwin, D- Wisconsin, issued the following news release:. U.S. Senator Tammy Baldwin joined 15 of her colleagues to call on the Department of Health and Human Services to take immediate action to reduce the price of naloxone, a life-saving opioid overdose reversal drug. "The Commission on Combating Drug Addiction and the Opioid Crisis recom
4/20/18 - FDA takes new steps to advance the development of innovative products for treating opioid use disorder
The first guidance, released today, explains the FDA's current thinking about drug development and clinical trial design issues relevant to the study of sustained-release "depot" buprenorphine products. "Today's action by FDA reflects the Trump Administration's commitment to bringing the best science we have to bear in the fight against opioid add
4/20/18 - Findings from KIST Provides New Data about Drug Delivery Systems (Implication of multivalent aptamers in DNA and DNA-RNA hybrid structures for...
For more information on this research see: Implication of multivalent aptamers in DNA and DNA-RNA hybrid structures for efficient drug delivery in vitro and in vivo. Journal of Industrial and Engineering Chemistry, 2018; 60: 250-258. Journal of Industrial and Engineering Chemistry can be contacted at: Elsevier Science Inc, 360 Park Ave South, New Y
4/20/18 - Findings from Mashhad University of Medical Sciences Yields New Data on Liposomes (Stable and sustained release liposomal formulations of celecoxib:...
Findings from Mashhad University of Medical Sciences Yields New Data on Liposomes. Financial support for this research came from Mashhad University of Medical Sciences. Our news journalists obtained a quote from the research from the Mashhad University of Medical Sciences, "Here, we developed liposomal drug delivery systems to allow a systemic...
4/20/18 - Findings in Antiretrovirals Reported from Department of Pharmaceutics and Pharmaceutical Technology (Targeted delivery of mannosylated-PLGA...
Findings in Antiretrovirals Reported from Department of Pharmaceutics and Pharmaceutical Technology. Our news editors obtained a quote from the research from the Department of Pharmaceutics and Pharmaceutical Technology, "Poly and mannosylated-PLGA NPs were prepared and administered by intravenous route in a dose of 10 mg/kg. The news editors repor
4/20/18 - Findings on Drug Delivery Systems Reported by Investigators at Queen's University [Hydrogels based on poly(methyl vinyl ether-co-maleic acid) and...
Findings on Drug Delivery Systems Reported by Investigators at Queen's University. According to news reporting originating from Belfast, United Kingdom, by NewsRx correspondents, research stated, "Hydrogels based on poly and Tween 85 were prepared for hydrophobic drug delivery. Our news editors obtained a quote from the research from Queen's Univer
4/20/18 - Findings on Drug Delivery Systems Reported by Investigators at University of Szeged [Mucoadhesive Cyclodextrin-Modified Thiolated Poly(aspartic acid)...
Findings on Drug Delivery Systems Reported by Investigators at University of Szeged. According to news reporting originating in Szeged, Hungary, by NewsRx journalists, research stated, "Thiolated poly is known as a good mucoadhesive polymer in aqueous ophthalmic formulations. The news reporters obtained a quote from the research from the University
4/20/18 - Global Intravenous Equipment Markets 2015-2018 & 2022: Focus on Intravenous Catheters, Intravenous Infusion Pumps and Sets
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. AngioDynamics, Inc. Animas Corporation Arcomed AG ASCOR S.A. B. Braun Melsungen AG Baxter International, Inc. Becton, Dickinson and Company C.R. Bard, Inc. F. Hoffmann-La Roche Ltd. Fresenius SE& Co. KGaA Halyard H
4/20/18 - Global Restless Legs Syndrome Therapeutics - 2018 Pipeline Analysis, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments - ResearchAndMarkets.com
In September 2017, AXIM Biotechnologies Inc. announced that it was conducting Phase I and a proof of concept clinical trial of MedChew RL for treatment of RLS in Israel. Alexza Pharmaceuticals Inc. is using its propriety staccato technology for the delivery of its development drug through inhalation. For instance, In April 2017, Merz Pharma GmbH& C
4/20/18 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 11759) - Meeting
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting of the Arthritis Advisory Committee to discuss new drug application 207924, for baricitinib tablets, submitted by Eli Lilly and Company, for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate resp
4/20/18 - Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO (fosnetupitant/ palonosetron) in the United States
Helsinn Healthcare SA/ Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO in the United States. Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO in the United States Lugano, Switzerland April 20, 2018- Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today ann
4/20/18 - Iterum Therapeutics Presents Data on Prevalence of Resistant Infections and Activity of its Novel Antibiotic Sulopenem
Iterum Therapeutics plc, a clinical-stage pharmaceutical company developing anti-infectives against multi-drug resistant pathogens, will deliver a mini-oral presentation and two additional posters at the European Congress of Clinical Microbiology in Madrid, Spain from April 21 to 24, 2018. Mini-Oral Presentation of ePoster 0736.
4/20/18 - Neurotechnology Innovations Translator (NIT) Announces Funding of up to $50 Million in Portfolio Company, Sollis Therapeutics
Led by New York firm Deerfield Management, the total funding includes additional capital and service commitments from NIT and its collaborators including the State of Ohio Development Services Agency, the Ohio Third Frontier, Medtronic, The Ohio State University, Cardinal Health, Battelle and Huntington Bank. The new capital infusion will support S
4/20/18 - New Drug Delivery Systems Data Have Been Reported by Investigators at Panjab University (Engineering design and mechanistic mathematical models:...
New Drug Delivery Systems Data Have Been Reported by Investigators at Panjab University. Our news journalists obtained a quote from the research from Panjab University, "The mathematical models simplify the analysis and optimize the design of therapeutic device to yield information on the efficacy of release models. For more information on this res
4/20/18 - New Drug Delivery Systems Findings Has Been Reported by Investigators at Chinese Academy of Sciences (Morphology-Variable Aggregates Prepared from...
New Drug Delivery Systems Findings Has Been Reported by Investigators at Chinese Academy of Sciences. According to news reporting originating in Shanghai, People's Republic of China, by NewsRx journalists, research stated, "In this study, a series of diblock glycopolymers, poly- b-poly, with cholesterol/galactose grafts were prepared through a sequ
4/20/18 - New Drug Delivery Systems Study Findings Have Been Reported by Investigators at Seoul National University of Science and Technology (pH Sensitive...
New Drug Delivery Systems Study Findings Have Been Reported by Investigators at Seoul National University of Science and Technology. According to news reporting originating from Seoul, South Korea, by NewsRx correspondents, research stated, "In this study, we evaluated contact lenses as drug delivery media and the effect of tear physiological pH on
4/20/18 - New Drug Delivery Systems Study Findings Have Been Reported by Investigators at University of Tanta (Preparation and Physicochemical Evaluation of...
New Drug Delivery Systems Study Findings Have Been Reported by Investigators at University of Tanta. According to news reporting out of Tanta, Egypt, by NewsRx editors, the research stated, "The purpose of this study is to prepare calcium silicate powder and to develop an optimal formulation based on calcium silicate for low-dose drug delivery.
4/20/18 - New Drug Delivery Systems Study Results from Sydney School of Medicine Described (The use of fatty acids as absorption enhancer for pulmonary drug...
According to news reporting originating from Sydney, Australia, by NewsRx correspondents, research stated, "A limitation in the systemic uptake of many inhalable drugs is the restricted permeation through the pulmonary epithelial layer barrier. Our news editors obtained a quote from the research from the Sydney School of Medicine, "In this study, t
4/20/18 - Patent Issued for Methods for Superdisintegrant-Based Composite Particles for Dispersion and Dissolution of Active Pharmaceutical Agents (USPTO...
Patent Issued for Methods for Superdisintegrant-Based Composite Particles for Dispersion and Dissolution of Active Pharmaceutical Agents. By a News Reporter-Staff News Editor at Drug Week New Jersey Institute of Technology has been issued patent number 9931300, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors
4/20/18 - Researchers from School of Pharmacy Detail Findings in Drug Delivery Systems (Design and evaluation of galactosylated chitosan/graphene oxide...
According to news reporting from Xiamen, People's Republic of China, by NewsRx journalists, research stated, "We investigated a novel drug delivery system comprising nanoparticles based on galactosylated chitosan/graphene oxide/doxorubicin for the therapeutic treatment of cancer. Financial supporters for this research include The Educational...
Articles(s): 1 - 25 of 105     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415